- Jan 03, 2019 -
Soy Lecithin (Lecithin High Potency and soybean Lecithin), is the byproduct in the process of refined soybean oil, is by solvent extraction and then after centrifugal separation is obtained by alcohol wash.
When scientists from the university of Texas health medical center (UTHealth) combined soy lecithin with a nonsteroidal anti-inflammatory drug (NSAID), they found increased cancer resistance and reduced side effects.
The researchers compared indomethacin, a nonsteroidal anti-inflammatory drug, with soy lecithin in combination with three other nsaids (one of which is aspirin) and found that the combination provided better anti-colorectal cancer benefits and reduced gastrointestinal bleeding. The study was a preclinical trial in a mouse model.
NSAIDs works by reducing the production of substances that promote inflammation, pain and fever. It is used to prevent heart disease and reduce arthritis pain. They can also be used to prevent colorectal cancer.
However, NSAIDs can also cause problems if the drug is taken daily for months or years on end, researchers say. For non-aspirin NSAIDs such as indomethacin, the damage to the gut is worse than for stomach ulcers. This is their latest preclinical trial showing that soy lecithin can reduce the side effects of NSAIDs and has potential anticancer effects.